7. Diabetes Technology: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Digital health for aging populations
Growing life expectancy poses important societal challenges, placing an increasing burden
on ever more strained health systems. Digital technologies offer tremendous potential for …
on ever more strained health systems. Digital technologies offer tremendous potential for …
American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update
L Blonde, GE Umpierrez, SS Reddy, JB McGill… - Endocrine Practice, 2022 - Elsevier
Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …
evidence-based recommendations for the comprehensive care of persons with diabetes …
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Continuous glucose monitoring–guided insulin administration in hospitalized patients with diabetes: a randomized clinical trial
EK Spanakis, A Urrutia, RJ Galindo, P Vellanki… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE The efficacy and safety of continuous glucose monitoring (CGM) in adjusting
inpatient insulin therapy have not been evaluated. RESEARCH DESIGN AND METHODS …
inpatient insulin therapy have not been evaluated. RESEARCH DESIGN AND METHODS …
Development of smartphone-controlled and microneedle-based wearable continuous glucose monitoring system for home-care diabetes management
J Yang, X Gong, S Chen, Y Zheng, L Peng, B Liu… - ACS …, 2023 - ACS Publications
Continuous glucose monitoring (CGM) can mini-invasively track blood glucose fluctuation
and reduce the risk of hyperglycemia and hypoglycemia, and this is is in great demand for …
and reduce the risk of hyperglycemia and hypoglycemia, and this is is in great demand for …
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024
Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes …
T Battelino, RM Bergenstal, A Rodríguez… - The Lancet Diabetes & …, 2022 - thelancet.com
Background Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP)
and GLP-1 receptor agonist under development for the treatment of type 2 diabetes. In this …
and GLP-1 receptor agonist under development for the treatment of type 2 diabetes. In this …
Long-term stable wireless smart contact lens for robust digital diabetes diagnosis
HH Han, SK Kim, SJ Kim, I Choi, JW Mok, CK Joo… - Biomaterials, 2023 - Elsevier
Wearable devices for digital continuous glucose monitoring (CGM) have attracted great
attention as a new paradigm medical device for diabetes management. However, the …
attention as a new paradigm medical device for diabetes management. However, the …
Opportunities and challenges for sweat-based monitoring of metabolic syndrome via wearable technologies
Metabolic syndrome is a prevalent condition in adults over the age of 65 and is a risk factor
for developing cardiovascular disease and type II diabetes. Thus, methods to track the …
for developing cardiovascular disease and type II diabetes. Thus, methods to track the …